Irhythm Technologies [IRTC] vs Boston Scientific [BSX] Detailed Stock Comparison
Irhythm Technologies
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Irhythm Technologies wins in 8 metrics, Boston Scientific wins in 10 metrics, with 0 ties. Boston Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Irhythm Technologies | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -43.66 | 61.39 | Irhythm Technologies |
| Price-to-Book Ratio | 49.09 | 6.81 | Boston Scientific |
| Debt-to-Equity Ratio | 708.80 | 53.09 | Boston Scientific |
| PEG Ratio | -86.14 | 36.97 | Irhythm Technologies |
| EV/EBITDA | -111.34 | 34.98 | Irhythm Technologies |
| Profit Margin (TTM) | -14.06% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -5.71% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | -91.14% | 11.55% | Boston Scientific |
| Return on Assets (TTM) | -3.53% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-45.55M | $2.37B | Boston Scientific |
| 1-Year Return | 123.27% | 35.37% | Irhythm Technologies |
| Price-to-Sales Ratio (TTM) | 7.75 | 8.26 | Irhythm Technologies |
| Enterprise Value | $5.28B | $164.56B | Boston Scientific |
| EV/Revenue Ratio | 8.04 | 8.90 | Irhythm Technologies |
| Gross Profit Margin (TTM) | 71.17% | 67.65% | Irhythm Technologies |
| Revenue per Share (TTM) | $21 | $13 | Irhythm Technologies |
| Earnings per Share (Diluted) | $-2.92 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 1.41 | 0.66 | Boston Scientific |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Irhythm Technologies vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Irhythm Technologies | -1.55% | -3.92% | 17.73% | 15.69% | 44.75% | 77.21% |
| Boston Scientific | 0.17% | -2.15% | 0.71% | -0.15% | -2.86% | 15.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Irhythm Technologies | 123.27% | 4.68% | -8.36% | 514.58% | 514.58% | 514.58% |
| Boston Scientific | 35.37% | 143.66% | 163.38% | 491.74% | 1,782.12% | 264.32% |
Performance & Financial Health Analysis: Irhythm Technologies vs Boston Scientific
| Metric | IRTC | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $5.09B | $152.83B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 678,940 | 6,224,340 |
| 90 Day Avg. Volume | 508,497 | 7,502,280 |
| Last Close | $158.50 | $103.14 |
| 52 Week Range | $55.92 - $168.32 | $74.01 - $108.94 |
| % from 52W High | -5.83% | -5.32% |
| All-Time High | $286.19 (Jan 25, 2021) | $108.94 (Jul 23, 2025) |
| % from All-Time High | -44.62% | -5.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.23% |
| Quarterly Earnings Growth | 0.26% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.14% |
| Operating Margin (TTM) | -0.06% | 0.19% |
| Return on Equity (TTM) | -0.91% | 0.12% |
| Debt to Equity (MRQ) | 708.80 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.23 | $15.14 |
| Cash per Share (MRQ) | $16.98 | $0.36 |
| Operating Cash Flow (TTM) | $63.35M | $4.28B |
| Levered Free Cash Flow (TTM) | $47.56M | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Irhythm Technologies vs Boston Scientific
| Metric | IRTC | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -43.66 | 61.39 |
| Forward P/E | -86.14 | 36.97 |
| PEG Ratio | -86.14 | 36.97 |
| Price to Sales (TTM) | 7.75 | 8.26 |
| Price to Book (MRQ) | 49.09 | 6.81 |
| Market Capitalization | ||
| Market Capitalization | $5.09B | $152.83B |
| Enterprise Value | $5.28B | $164.56B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.04 | 8.90 |
| Enterprise to EBITDA | -111.34 | 34.98 |
| Risk & Other Metrics | ||
| Beta | 1.41 | 0.66 |
| Book Value per Share (MRQ) | $3.23 | $15.14 |
Financial Statements Comparison: Irhythm Technologies vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IRTC | BSX |
|---|---|---|
| Revenue/Sales | $158.68M | $4.66B |
| Cost of Goods Sold | $49.46M | $1.45B |
| Gross Profit | $109.22M | $3.21B |
| Research & Development | $21.82M | $443.00M |
| Operating Income (EBIT) | $-32.56M | $937.00M |
| EBITDA | $-20.95M | $1.23B |
| Pre-Tax Income | $-30.04M | $805.00M |
| Income Tax | $665,000 | $133.00M |
| Net Income (Profit) | $-30.70M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IRTC | BSX |
|---|---|---|
| Cash & Equivalents | $375.28M | $725.00M |
| Total Current Assets | $636.01M | $7.34B |
| Total Current Liabilities | $111.34M | $5.06B |
| Long-Term Debt | $719.36M | $10.93B |
| Total Shareholders Equity | $86.67M | $22.45B |
| Retained Earnings | $-789.60M | $3.35B |
| Property, Plant & Equipment | $55.71M | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IRTC | BSX |
|---|---|---|
| Operating Cash Flow | $-31.20M | $513.00M |
| Capital Expenditures | $-9.42M | $-187.00M |
| Free Cash Flow | $-17.31M | $277.00M |
| Debt Repayment | $0 | $-1.31B |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IRTC | BSX |
|---|---|---|
| Shares Short | 2.49M | 19.57M |
| Short Ratio | 5.55 | 2.65 |
| Short % of Float | 0.09% | 0.01% |
| Average Daily Volume (10 Day) | 678,940 | 6,224,340 |
| Average Daily Volume (90 Day) | 508,497 | 7,502,280 |
| Shares Outstanding | 31.39M | 1.47B |
| Float Shares | 31.74M | 1.48B |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.14% | 0.93% |
Dividend Analysis & Yield Comparison: Irhythm Technologies vs Boston Scientific
| Metric | IRTC | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |